International Clinical Trial: Entinostat in Combination with CDK4/6 Inhibitors and Endocrine Therapy: A Single-Arm, Exploratory Phase II Clinical Trial in Patients with Treatment-Naive Advanced HR+/HER2-Negative Breast Cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132757) titled 'Entinostat in Combination with CDK4/6 Inhibitors and Endocrine Therapy: A Single-Arm, Exploratory Phase II Clinical Trial in Patients with Treatment-Naive Advanced HR+/HER2-Negative Breast Cancer' on Sept. 18.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: HenanCancerHospital

Condition: HR+/HER2-Breast Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-18

Target Sample Size: Experimental group:70;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=333253

Published by HT Digital Content Se...